Table 2.
Cargo Type | Exosomal Cargo | Biofluids | Extraction Method | Identification Method | Detection Method | Clinical Value | Reference |
---|---|---|---|---|---|---|---|
miRNA | miR-652-5p | Serum | Differential centrifugation | Flow cytometry | qRT-PCR | Reduced expression in EC patients | [66] |
miR-21 | Serum | Commercial kit | Not shown | qRT-PCR | Related to lymphatic metastasis and stage | [67] | |
miR-766-3p | Serum | Commercial kit | TEM and Western blot | miRNA profiling, qRTPCR | Indicator for poor prognosis | [68] | |
miR-182 | Serum | Commercial kit | Not shown | qRT-PCR | Indicator for poor prognosis | [69] | |
miR-340-5p | Plasma | Differential centrifugation | TEM, NTA and Western blot | qRT-PCR | Indicator for radioresistance and poor prognosis | [57] | |
miR-339-5p | Serum | Differential centrifugation | TEM and Western blot | qRT-PCR | Predicts response to preoperative radiotherapy | [58] | |
lncRNA | PCAT1 | Serum | Ultracentrifugation | TEM and NTA | qRT-PCR | Higher expression in EC patients | [21] |
UCA1 | Plasma | Ultracentrifugation | TEM, NTA and Western blot | qRT-PCR | Biomarker for diagnosis of EC | [73] | |
UCA1, POU3F3, ESCCAL-1 and PEG10 | Serum | Commercial kit | TEM, NTA and Western blot | qRT-PCR | Biomarker for diagnosis of EC | [74] | |
circRNA | circ-0026611 | Serum | Commercial kit | TEM and Western blot | circRNA microarray, qRT-PCR | Related to lymphatic metastasis and stage | [77] |
Protein | Stathmin-1 | Serum | Ultracentrifugation | TEM, NTA and Western blot | ELISA | Indicator for poor prognosis | [79] |
RNA | seG-chiRNA | Salivary | Commercial kit | TEM, NTA and Western blot | qRT-PCR | Predicts recurrence and therapeutic response of EC | [82] |
Abbreviations: EC, esophageal cancer; ELISA, enzyme-linked immunosorbent assay; NTA, nanoparticle tracking analysis; qRT-PCR, quantitative real time polymerase chain reaction; TEM, transmission electron microscope.